title: [Treatment of hepatorenal syndrome with dopamine and bromocriptine].
abstract: Two cirrhotic patients with hepatorenal syndrome were treated with Dopamine hydrochloride and Bromocriptine, a Dopamine agonist. Dopamine hydrochloride was given at a dosis of 0.30 to 0.90 mg/min. and Bromocriptine 15 mg/day. Although a transient raise of urinary output was observed in one patient, both patients died six to ten days later with an urinary output of less than 100 ml/day. Dopamine and Bromocriptine combined are of poor therapeutic value in hepatorenal syndrome.
mesh_terms: D000328:Adult; D001971:Bromocriptine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004298:Dopamine / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006505:Hepatitis / Q000150:complications; D006801:Humans; D007275:Injections, Intravenous; D007674:Kidney Diseases / Q000188:drug therapy*; D008103:Liver Cirrhosis / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D008875:Middle Aged
chemical_list: D001971:Bromocriptine; D004298:Dopamine
vernacular_title: Tratamiento del síndrome hepatorrenal con dopamina y bromocriptina.